SynDRA canonical compound SYN0041651 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Primary target(s) | ALOX5 | DGKA | NR1I2 | PPP2CA | PPP2CB | PRKCA | PRKCB | SEC14L2 | SEC14L3 | SEC14L4 |
| Mechanism of action | LDL oxidation inhibitor | PKC inhibitor |